October 16, 2023-October 17, 2023 Fall 2023 HRA Members Meeting This October 16-17, in Chicago, IL members of C-Path’s CDRC team will join the Health Research Alliance’s Members Meet
October 16, 2023 Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals.
October 11, 2023-October 15, 2023 IDWeek 2023 Hosted in Boston, Mass. from October 11-15, IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA
October 11, 2023 Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study To address the challenges of assessing the impact of a reasonably likely surrogate endpoint on long-term graft survival....
October 6, 2023 Innovative Trial Design Approaches to Model Informed Drug Development in Rare and Neurological Diseases Are you passionate about making a difference in the fields of neurology and rare diseases? Do you want to explore new methods that
October 3, 2023 C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research TUCSON, Ariz., October 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Confer
October 2, 2023-October 6, 2023 View Now — European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and Reception Members of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 D
September 28, 2023-September 29, 2023 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s Predictive Safety Testing Consortium hosted a public workshop on September 28-29, 2023 in Bethesda, Ma
September 25, 2023 Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant.
September 20, 2023 The CPP Consortium Welcomes Biohaven as its Newest Member The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopha